0
Original Research: HYPOXIA-RELATED ISSUES |

Does Endothelin Play a Role in Chemoreception During Acute Hypoxia in Normal Men?*

Marko Gujic, MD; Anne Houssière, PT; Olivier Xhaët, MD; Jean-François Argacha, MD; Nathalie Denewet, BS; André Noseda, MD, PhD; Pascale Jespers, BS; Christian Melot, MD, PhD, MscBiostat; Robert Naeije, MD, PhD; Philippe van de Borne, MD, PhD
Author and Funding Information

*From the Departments of Cardiology (Drs. Gujic, Xhaët, Argacha, and van de Borne, Ms. Houssière, and Ms. Denewet), Pneumology (Dr. Noseda), and Physiology (Ms. Jespers and Dr. Naeije), and the Intensive Care Unit (Dr. Melot), Erasme Hospital, Brussels, Belgium.

Correspondence to: Marko Gujic, MD, Department of Cardiology, Erasme University Hospital, 808 Lennik Rd, B-1070 Brussels, Belgium; e-mail: marko.gujic@ulb.ac.be



Chest. 2007;131(5):1467-1472. doi:10.1378/chest.06-1775
Text Size: A A A
Published online

Background: The peripheral chemoreceptors are the dominant reflex mechanism responsible for the rise in ventilation and muscle sympathetic nerve activity (MSNA) in response to hypoxia. Animal studies have suggested that endothelin (ET) plays an important role in chemosensitivity. Moreover, several human clinical conditions in which circulating ET levels are increased are accompanied by enhanced chemoreflex sensitivity. Whether ET plays a role in normal human chemosensitivity is unknown.

Methods: We determined whether bosentan, a nonspecific ET receptor antagonist, would decrease chemoreflex sensitivity in 14 healthy subjects. We assessed the effects of bosentan on the response to isocapnic hypoxia, using a randomized, crossover, double-blinded study design.

Results: Bosentan increased mean (± SEM) plasma ET levels from 1.97 ± 0.28 to 2.53 ± 0.23 pg/mL (p = 0.01). Hypoxia increased mean minute ventilation from 6.7 ± 0.3 to 8+/0.4 L/min (p < 0.01), mean MSNA from 100 to 111 ± 5% (p < 0.01), mean heart rate from 67 ± 3 to 86 ± 3 beats/min (p < 0.01), and mean systolic BP from 116 ± 3 to 122 ± 3 mm Hg (p < 0.01). However, none of these responses differed between therapy with bosentan and therapy with placebo (p = 0.26). Bosentan did not affect the mean MSNA responses to the apneas, during normoxia (change from baseline: placebo, 259 ± 58%; bosentan, 201 ± 28%; p = 0.17) or during hypoxia (change from baseline: placebo, 469 ± 139%; bosentan, 329 ± 46%; p = 0.24). The durations of the voluntary end-expiratory apneas in normoxia and hypoxia, and the subsequent reductions in oxygen saturation, were also similar with therapy using bosentan and placebo (p = 0.42).

Conclusion: In healthy men, ET does not play an important role in peripheral chemoreceptor activation by acute hypoxia.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543